News | November 06, 2024
Venus Remedies gets approval from Malaysian PIC/S GMP for pre-filled syringe facility
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
This is in pursuance to the announcement made in the Union Budget for the year 2024-25 exempting these three anti-cancer medicines from customs duty
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Subscribe To Our Newsletter & Stay Updated
